| Enriched cancer pathway | Genes under regulation | P value |
|---|
| Gap junction |
5 genes: MAP3K2, EGFR, GJA1, GUCY1A2, ITPR2
|
0.004587 |
| GnRH signaling pathway |
5 genes: MAP3K2, EGFR, ITPR2, CACNA1C, CAMK2A
|
0.007438 |
| Long.term potentiation |
4 genes: GRIN2A, ITPR2, CACNA1C, CAMK2A
|
0.009992 |
| Long.term depression |
4 genes: GNAO1, GUCY1A2, ITPR2, LYN
|
0.009992 |
| Vascular smooth muscle contraction |
5 genes: MRVI1, ARHGEF12, GUCY1A2, ITPR2, CACNA1C
|
0.01305 |
| Calcium signaling pathway |
6 genes: EGFR, GRIN2A, ITPR2, PDE1B, CACNA1C, CAMK2A
|
0.02019 |
| Axon guidance |
5 genes: NFAT5, DPYSL2, ARHGEF12, PLXNA2, SLIT3
|
0.02038 |
| Wnt signaling pathway |
5 genes: NFAT5, CSNK1A1, PPP2R5E, CAMK2A, FZD1
|
0.03571 |
| Dorso.ventral axis formation |
2 genes: EGFR, ETS1
|
0.03589 |
| Glycosaminoglycan biosynthesis . heparan sulfate |
2 genes: NDST1, XYLT1
|
0.03858 |
| MAPK signaling pathway |
7 genes: MAP3K2, DUSP8, EGFR, MAPT, SRF, CACNA1C, MAP4K4
|
0.04342 |